J
Jan-Gerd Kresken
Publications - 11
Citations - 478
Jan-Gerd Kresken is an academic researcher. The author has contributed to research in topics: Pimobendan & Heart failure. The author has an hindex of 6, co-authored 11 publications receiving 380 citations.
Papers
More filters
Journal ArticleDOI
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Jens Häggström,Adrian Boswood,Michael R. O'Grady,Olaf Jöns,Sarah Smith,Simon Swift,M. Borgarelli,B. Gavaghan,Jan-Gerd Kresken,M. Patteson,B. Åblad,Claudio Bussadori,Tony M. Glaus,A. Kovacevic,M. Rapp,Roberto A. Santilli,Anna Tidholm,A. Eriksson,M.C. Belanger,M. Deinert,C.J.L. Little,Clarence Kvart,Anne French,M. Ronn-Landbo,Gerhard Wess,A.V. Eggertsdottir,M.L. O'Sullivan,Matthias Schneider,Christophe W. Lombard,Joanna Dukes-McEwan,Ruth Willis,A. Louvet,Rocky DiFruscia +32 more
TL;DR: Pimobendan plus conventional therapy prolongs time to sudden death, euthanasia for cardiac reasons, or treatment failure in dogs with CHF caused by MMVD compared with benazeprilplus conventional therapy.
Journal ArticleDOI
Effect of Body Weight on Echocardiographic Measurements in 19,866 Pure-Bred Cats with or without Heart Disease.
Jens Häggström,Å.O. Andersson,T. Falk,L. Nilsfors,U. OIsson,Jan-Gerd Kresken,Katja Höglund,Mark Rishniw,Anna Tidholm,Ingrid Ljungvall +9 more
TL;DR: BW had a clinically relevant effect on echocardiographic dimensions in cats, and BW based 95% prediction intervals may help in screening cats for heart disease.
Journal ArticleDOI
Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving Pimobendan or Benazepril: the QUEST study
Jens Häggström,Adrian Boswood,Michael R. O'Grady,Olaf Jöns,Sarah Smith,Simon Swift,M. Borgarelli,B. Gavaghan,Jan-Gerd Kresken,M. Patteson,B. Åblad,Claudio Bussadori,Toni M Glaus,A. Kovacevic,M. Rapp,Roberto A. Santilli,Anna Tidholm,A. Eriksson,M.C. Belanger,M. Deinert,C.J.L. Little,Clarence Kvart,Anne French,M. Ronn-Landbo,Gerhard Wess,A.V. Eggertsdottir,M. Lynne O'Sullivan,Matthias Schneider,Christophe W. Lombard,Joanna Dukes-McEwan,Ruth Willis,A. Louvet,Rocky DiFruscia +32 more
TL;DR: Pimobendan versus benazepril resulted in similar QoL during the study, but conferred increased time before intensification of CHF treatment.
Journal ArticleDOI
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo : The EPIC Study
Adrian Boswood,Sonya G. Gordon,Jens Häggström,Gerhard Wess,Rebecca L. Stepien,Mark A. Oyama,Bruce W. Keene,John D. Bonagura,Kristin A. MacDonald,M. Patteson,Sarah Smith,Philip R. Fox,Karen Sanderson,Richard Woolley,Viktor Szatmári,Pierre Menaut,Whitney M. Church,M.L. O'Sullivan,J. P. Jaudon,Jan-Gerd Kresken,John E. Rush,Kirstie A. Barrett,Steven L. Rosenthal,Ashley B. Saunders,Ingrid Ljungvall,M. Deinert,Eric Bomassi,Amara H. Estrada,M. J. Fernández del Palacio,N.S. Moïse,Jonathan A. Abbott,Yoko Fujii,Alan W. Spier,Michael W. Luethy,Roberto A. Santilli,Masami Uechi,Anna Tidholm,Christoph Matthias Schummer,P. Watson +38 more
TL;DR: Pimobendan treatment reduces heart size and is associated with improved outcome and relationships between short‐term changes in echocardiographic variables and time to CHF or CRD were explored.
Journal ArticleDOI
Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial.
Gerhard Wess,Jan-Gerd Kresken,Ralph T. Wendt,Juliane Gaugele,M. Killich,Lisa Keller,Julia Simak,Peter Holler,Alexander Bauer,Helmut Küchenhof,Tony M. Glaus +10 more
TL;DR: Addition of the ACEI ramipril to pimobendan and furosemide did not have any beneficial effect on survival time in dogs with CHF secondary to MMVD.